Evidence map›Paper›PMID 22246226›Full record

ReviewNeurochemical research2012

It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation.

Erhard Bieberich

Abstract readReview
In one paragraph

Review in Neurochemical research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Review
  3. Biological nanoparticles from Brucella abortusJournal of nanobiotechnology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. LC/MS-Based Untargeted Lipidomics Reveals Lipid Signatures of Sarcopenia.International journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Erhard BieberichInstitute of Molecular Medicine and Genetics, Georgia Health Sciences University, 1120 15th Street Room CA4012, Augusta, GA 30912, USA. ebieberich@georgiahealth.edu
Augusta University Health · US

Funding

Function of ceramide in neurodegenerative diseaseR01AG034389 · NIA · UNIVERSITY OF KENTUCKY · PI BIEBERICH, ERHARD · 2010 to 2020
$3.6M
NIA NIH HHS R01 AG034389NIA NIH HHS R01AG034389
6 · The paper itself

Abstract

Lipids are often considered membrane components whose function is to embed proteins into cell membranes. In the last two decades, studies on brain lipids have unequivocally demonstrated that many lipids have critical cell signaling functions; they are called "bioactive lipids". Pioneering work in Dr. Robert Ledeen's laboratory has shown that two bioactive brain sphingolipids, sphingomyelin and the ganglioside GM1 are major signaling lipids in the nuclear envelope. In addition to derivatives of the sphingolipid ceramide, the bioactive lipids discussed here belong to the classes of terpenoids and steroids, eicosanoids, and lysophospholipids. These lipids act mainly through two mechanisms: (1) direct interaction between the bioactive lipid and a specific protein binding partner such as a lipid receptor, protein kinase or phosphatase, ion exchanger, or other cell signaling protein; and (2) formation of lipid microdomains or rafts that regulate the activity of a group of raft-associated cell signaling proteins. In recent years, a third mechanism has emerged, which invokes lipid second messengers as a regulator for the energy and redox balance of differentiating neural stem cells (NSCs). Interestingly, developmental niches such as the stem cell niche for adult NSC differentiation may also be metabolic compartments that respond to a distinct combination of bioactive lipids. The biological function of these lipids as regulators of NSC differentiation will be reviewed and their application in stem cell therapy discussed.

Indexed as

AnimalsCell DifferentiationCeramidesEnergy MetabolismGangliosidesGlobosidesHumansLipidsLysophospholipidsMAP Kinase Signaling SystemMembrane MicrodomainsNeural Stem CellsPhosphatidylinositolsReceptors, Cell SurfaceReceptors, Cytoplasmic and NuclearReceptors, sigmaCeramidesGangliosidesGlobosidesLipidslysophosphatidic acidLysophospholipidsPhosphatidylinositolsReceptors, Cell SurfaceReceptors, Cytoplasmic and NuclearReceptors, sigmaSphingosinesphingosine 1-phosphate

Identifiers

PMID22246226
PMCPMC3343224
OpenAlexW1981322447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.